Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Yoneda

Showing results (11-20 of 454) with videos related to

Pageof 46
Sort By:
Clinical Endoscopy|January 12, 2026
Successful treatment of a complete obstruction at the hepaticojejunostomy anastomosis using cholangioscopic biopsy forceps inserted via the endoscopic ultrasound-guided hepaticogastrostomy routeSho Hasegawa, Kunihiro Hosono, Masato Yoneda
Journal of Hepato-Biliary-Pancreatic Sciences|August 21, 2025
Successful Closure of an Enterocutaneous Fistula Associated With Surgical Site Infection After Pancreatoduodenectomy Using an Over-the-Scope Clip SystemSho Hasegawa, Itaru Endo, Masato Yoneda
Hepatobiliary Surgery and Nutrition|September 18, 2018
Will the magnetic resonance imaging proton density fat fraction replace liver biopsy as the gold standard for detecting steatosis?Masato Yoneda, Kento Imajo, Atsushi Nakajima
Alimentary Pharmacology & Therapeutics|May 27, 2023
Editorial: optimal combination of non-invasive tests to determine significant fibrosis in non-alcoholic fatty liver diseaseAsako Nogami, Atsushi Nakajima, Masato Yoneda
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 23, 2015
ReplyMasato Yoneda, Emmanuel Thomas, Eugene R Schiff
Cold Spring Harbor Perspectives in Medicine|February 4, 2015
Viral hepatitis: past and future of HBV and HDVEmmanuel Thomas, Masato Yoneda, Eugene R Schiff
Expert Opinion on Pharmacotherapy|April 21, 2021
What considerations are there for the pharmacotherapeutic management of nonalcoholic steatohepatitis?Masato Yoneda, Yasushi Honda, Satoru Saito, et al.
Internal Medicine (Tokyo, Japan)|June 11, 2019
Neuroendocrine Tumor Treated with Arterial Chemoembolization Using DEB-TACEKo Suzuki, Masato Yoneda, Noritoshi Kobayashi, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|October 14, 2006
[PPAR gamma ligand pioglitazone as a therapeutic strategy in nonalcoholic steatohepatitis (NASH)]Masato Yoneda, Koji Fujita, Atsushi Nakajima, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 12, 2013
[Pathophysiology of NAsh/NAFLD associated with high levels of serum triglycerides]Yuji Ogawa, Kento Imajo, Masato Yoneda, et al.
Pageof 46

Showing results (11-20 of 454) with videos related to

Sort By:
Pageof 46
Clinical Endoscopy|January 12, 2026
Successful treatment of a complete obstruction at the hepaticojejunostomy anastomosis using cholangioscopic biopsy forceps inserted via the endoscopic ultrasound-guided hepaticogastrostomy routeSho Hasegawa, Kunihiro Hosono, Masato Yoneda
Journal of Hepato-Biliary-Pancreatic Sciences|August 21, 2025
Successful Closure of an Enterocutaneous Fistula Associated With Surgical Site Infection After Pancreatoduodenectomy Using an Over-the-Scope Clip SystemSho Hasegawa, Itaru Endo, Masato Yoneda
Hepatobiliary Surgery and Nutrition|September 18, 2018
Will the magnetic resonance imaging proton density fat fraction replace liver biopsy as the gold standard for detecting steatosis?Masato Yoneda, Kento Imajo, Atsushi Nakajima
Alimentary Pharmacology & Therapeutics|May 27, 2023
Editorial: optimal combination of non-invasive tests to determine significant fibrosis in non-alcoholic fatty liver diseaseAsako Nogami, Atsushi Nakajima, Masato Yoneda
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 23, 2015
ReplyMasato Yoneda, Emmanuel Thomas, Eugene R Schiff
Cold Spring Harbor Perspectives in Medicine|February 4, 2015
Viral hepatitis: past and future of HBV and HDVEmmanuel Thomas, Masato Yoneda, Eugene R Schiff
Expert Opinion on Pharmacotherapy|April 21, 2021
What considerations are there for the pharmacotherapeutic management of nonalcoholic steatohepatitis?Masato Yoneda, Yasushi Honda, Satoru Saito, et al.
Internal Medicine (Tokyo, Japan)|June 11, 2019
Neuroendocrine Tumor Treated with Arterial Chemoembolization Using DEB-TACEKo Suzuki, Masato Yoneda, Noritoshi Kobayashi, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|October 14, 2006
[PPAR gamma ligand pioglitazone as a therapeutic strategy in nonalcoholic steatohepatitis (NASH)]Masato Yoneda, Koji Fujita, Atsushi Nakajima, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 12, 2013
[Pathophysiology of NAsh/NAFLD associated with high levels of serum triglycerides]Yuji Ogawa, Kento Imajo, Masato Yoneda, et al.
Pageof 46